Info
🌱來自: snippets
ESRD
Recommendations on the management of the clinical frequently used chemotherapeutic agents in patients undergoing dialysis according to Janus et al and Tomita et al *5FU standard dose After HD *Capecitabine reduced 50% *Cisplatin reduced 50-75% After HD *Cyclophosphamide reduced 25% After HD *Docetaxel 65mg/m2 before or after HD *Doxorubicin standard dose After HD *Epirubicin standard dose After HD *Etoposide reduced 4-50% before or after HD *Gemcitabine standard dose 6-12 hours before HD *Ifosfamide not recommended *irinotecan reduced to 50mg/m2/week after HD *MTX reduced 75% after HD *Oxaliplatin reduced 30% after HD *Taxol standard dose before or after HD *Vcb reduced 25-33% after HD
Siblings
- PANCREATIC_ADJ
- AMPULLA
- ANAL
- APTT
- Comfirmed COVID on ?
- APTTPT
- Adrenal
- BCADJ
- BCADJH
- BCFU
- BCMET
- BMD
- BREASTPE
- Bruising
- CCC
- CHEMOAE
- CRCADJ
- CRCCHEMOAE
- CRCFU
- CRCM
- DTIC
- ESOCA
- ESRD
- EYE
- FL
- GB
- GBM
- GC
- GCA
- GCFU
- GIST
- HBV
- HCC
- HNSCCAE
- HNSCCAECCRT
- HP
- HYPERLIPIDEMIA
- IDA
- INDUCTIONBC
- IO
- ImatinibNIH
- KARNOFSKYPS
- LAP
- LUNGNET
- LUNGNETS
- MEGESTROL
- MYELOMA
- NET
- NSCLC
- NSCLCADJ
- NSCLCFU
- PANCREATIC
- PE
- PEGI
- PGNG
- PLT
- PNET
- RECTALADJ
- RECTALCCRT
- RECTALNET